Profiel
Arvinder Dhalla is currently Vice President-Clinical Operations at Rani Therapeutics LLC and Vice President-Clinical Development at Rani Therapeutics Holdings, Inc. Formerly, Dr. Dhalla was Biology Director-Cardiovascular Therapeutic at Gilead Sciences, Inc. from 2009 to 2015.
Education includes a doctorate from the University of Manitoba and undergraduate and graduate degrees from Panjab University Chandigarh.
Actieve functies van Arvinder Dhalla
| Bedrijven | Functie | Begin |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2021 |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Operationeel Directeur | - |
Eerdere bekende functies van Arvinder Dhalla
| Bedrijven | Functie | Einde |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-01-2015 |
Opleiding van Arvinder Dhalla
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
University of Manitoba
University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panjab University Chandigarh
Panjab University Chandigarh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins and antibodies | Health Technology |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
















